https://pmc.ncbi.nlm.nih.gov/articles/PMC10727911/
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for...
Prior trials suggest that intravenous racemic ketamine is a highly effective for treatment-resistant depression (TRD), but phase 3 trials of racemic ketamine...
efficacy and safety4 week course